|
1
|
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.
|
Proc Natl Acad Sci U S A
|
2005
|
6.64
|
|
2
|
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
|
J Virol
|
2006
|
5.41
|
|
3
|
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.
|
J Infect Dis
|
2011
|
3.78
|
|
4
|
Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.
|
J Infect Dis
|
2004
|
3.30
|
|
5
|
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.
|
Clin Infect Dis
|
2005
|
3.06
|
|
6
|
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
|
Gastroenterology
|
2008
|
3.00
|
|
7
|
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.
|
J Virol
|
2006
|
2.91
|
|
8
|
Cellular immune selection with hepatitis C virus persistence in humans.
|
J Exp Med
|
2005
|
2.75
|
|
9
|
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
|
J Virol
|
2005
|
2.61
|
|
10
|
Needlestick transmission of hepatitis C.
|
JAMA
|
2002
|
2.55
|
|
11
|
Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.
|
Hepatology
|
2005
|
2.52
|
|
12
|
Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
|
Gastroenterology
|
2009
|
2.24
|
|
13
|
Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.
|
Hepatology
|
2012
|
2.14
|
|
14
|
Humoral immune response in acute hepatitis C virus infection.
|
Clin Infect Dis
|
2005
|
2.02
|
|
15
|
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
|
J Infect Dis
|
2007
|
1.96
|
|
16
|
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.
|
J Infect Dis
|
2009
|
1.93
|
|
17
|
Cross-genotype immunity to hepatitis C virus.
|
J Virol
|
2004
|
1.92
|
|
18
|
Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
|
Gastroenterology
|
2009
|
1.89
|
|
19
|
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
|
J Virol
|
2002
|
1.88
|
|
20
|
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.
|
J Virol
|
2004
|
1.85
|
|
21
|
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
|
J Immunol
|
2008
|
1.79
|
|
22
|
Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
|
J Virol
|
2010
|
1.66
|
|
23
|
Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
|
J Virol
|
2008
|
1.66
|
|
24
|
Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
|
AIDS Res Hum Retroviruses
|
2007
|
1.63
|
|
25
|
A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
|
J Virol Methods
|
2006
|
1.49
|
|
26
|
Hepatitis C virus infection of neuroepithelioma cell lines.
|
Gastroenterology
|
2010
|
1.35
|
|
27
|
Molecular epidemiology of HIV-1 subtypes in southern China.
|
J Acquir Immune Defic Syndr
|
2005
|
1.33
|
|
28
|
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
|
J Virol
|
2005
|
1.32
|
|
29
|
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.
|
Hepatology
|
2014
|
1.29
|
|
30
|
CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load.
|
Clin Infect Dis
|
2008
|
1.29
|
|
31
|
Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire.
|
J Immunol
|
2008
|
1.28
|
|
32
|
Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons.
|
J Clin Microbiol
|
2004
|
1.26
|
|
33
|
Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver.
|
Gastroenterology
|
2013
|
1.23
|
|
34
|
Analysis of HIV diversity using a high-resolution melting assay.
|
AIDS Res Hum Retroviruses
|
2010
|
1.23
|
|
35
|
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy.
|
AIDS Patient Care STDS
|
2008
|
1.22
|
|
36
|
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.
|
J Virol
|
2009
|
1.20
|
|
37
|
Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
|
J Virol
|
2010
|
1.18
|
|
38
|
Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.
|
Retrovirology
|
2010
|
1.10
|
|
39
|
Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples.
|
Clin Infect Dis
|
2008
|
1.04
|
|
40
|
Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms.
|
AIDS Res Hum Retroviruses
|
2011
|
1.01
|
|
41
|
Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.
|
AIDS
|
2009
|
1.00
|
|
42
|
Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance.
|
J Clin Invest
|
2014
|
0.99
|
|
43
|
Maternal neutralizing antibody and transmission of hepatitis C virus to infants.
|
J Infect Dis
|
2008
|
0.97
|
|
44
|
Characterization of novel recombinant HIV-1 genomes using the branching index.
|
Virology
|
2003
|
0.97
|
|
45
|
Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India.
|
Indian J Med Res
|
2010
|
0.96
|
|
46
|
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
|
J Virol
|
2007
|
0.94
|
|
47
|
Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.
|
Virology
|
2011
|
0.92
|
|
48
|
Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.
|
J Immunol
|
2012
|
0.91
|
|
49
|
HIV-1 evolution following transmission to an HLA-B*5801-positive patient.
|
J Infect Dis
|
2009
|
0.91
|
|
50
|
Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.
|
Hepatology
|
2012
|
0.89
|
|
51
|
High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.
|
Hepatology
|
2009
|
0.89
|
|
52
|
Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure.
|
J Virol
|
2012
|
0.85
|
|
53
|
Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome.
|
J Virol
|
2012
|
0.85
|
|
54
|
The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
|
BMC Gastroenterol
|
2011
|
0.85
|
|
55
|
Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.
|
J Acquir Immune Defic Syndr
|
2008
|
0.85
|
|
56
|
Severe pruritus after completing pegylated interferon for hepatitis C.
|
AIDS Read
|
2008
|
0.77
|
|
57
|
Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination.
|
J Virol
|
2010
|
0.75
|
|
58
|
Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients.
|
Hepatology
|
2014
|
0.75
|
|
59
|
Intracellular HIV-1 rna and CD4+ t cell activation in patients starting antiretrovirals.
|
AIDS
|
2017
|
0.75
|
|
60
|
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.
|
JCI Insight
|
2017
|
0.75
|
|
61
|
Genomic Diversity of SARS-CoV-2 During Early Introduction into the United States National Capital Region.
|
medRxiv
|
2020
|
0.75
|
|
62
|
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1).
|
J Med Chem
|
2017
|
0.75
|